Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

The management of patients with atrial fibrillation (AF) has rapidly changed with increasing use of non-vitamin K antagonist oral anticoagulants (NOACs) and changes in the use of rhythm control therapy. The prevention of thromboembolic events European Registry in Atrial Fibrillation Prolongation Reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Renda, Giulia, Pecen, Ladislav, Patti, Giuseppe, Ricci, Fabrizio, Kotecha, Dipak, Siller-Matula, Jolanta M., Schnabel, Renate B., Wachter, Rolf, Sellal, Jean-Marc, Rohla, Miklos, Lucerna, Markus, Huber, Kurt, Verheugt, Freek W. A., Zamorano, Jose Luis, Brüggenjürgen, Bernd, Darius, Harald, Duytschaever, Mattias, Le Heuzey, Jean-Yves, Schilling, Richard J., Kirchhof, Paulus, De Caterina, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049932/
https://www.ncbi.nlm.nih.gov/pubmed/32955677
http://dx.doi.org/10.1007/s11739-020-02442-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049932/
https://www.ncbi.nlm.nih.gov/pubmed/32955677
http://dx.doi.org/10.1007/s11739-020-02442-9

Ejemplares similares